CA3219718A1 - Stent for bifurcated vessel - Google Patents
Stent for bifurcated vessel Download PDFInfo
- Publication number
- CA3219718A1 CA3219718A1 CA3219718A CA3219718A CA3219718A1 CA 3219718 A1 CA3219718 A1 CA 3219718A1 CA 3219718 A CA3219718 A CA 3219718A CA 3219718 A CA3219718 A CA 3219718A CA 3219718 A1 CA3219718 A1 CA 3219718A1
- Authority
- CA
- Canada
- Prior art keywords
- stent
- bifurcated
- vessels
- vessel
- conduits
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000031481 Pathologic Constriction Diseases 0.000 claims description 19
- 208000037804 stenosis Diseases 0.000 claims description 19
- 230000036262 stenosis Effects 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 16
- 241000124008 Mammalia Species 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 14
- 238000013461 design Methods 0.000 description 4
- 230000002792 vascular Effects 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000008952 Iliac Aneurysm Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000004692 intercellular junction Anatomy 0.000 description 1
- 238000002697 interventional radiology Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/856—Single tubular stent with a side portal passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/954—Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/0006—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting angular orientation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
A stent for use with occluded bifurcated vessels. The stent includes two elongate conduits both with a mesh sidewall and angled ends. A connector connects the angled ends so that they face each other to form a V-shaped gap. The connector is hingeably deformable so that the conduits are angled towards each other for location near a junction between the bifurcated vessels. This locates conduits in each of the bifurcated vessels.
Description
STENT FOR BIFURCATED VESSEL
TECHNICAL FIELD
The present generally concerns stents, and more specifically for a stent for use in narrowed vascular bifurcation.
BACKGROUND
Anatomic vessels have lumens in which a stenosis can form causing partial or complete occlusion. Stents are well-known and widely used in interventional radiology and cardiology to maintain the vessel open. Two designs are currently available, namely self expandible and balloon expandible stents. Both stent designs have metallic mesh-shaped structures, which when deployed in the vessel through minimally invasive vascular access, form scaffolding to avoid the recoil of the vessel wall so as to keep the vessel open. The mesh includes different, large cells which give the self-expanding stent more flexibility with less radial force, whereas the balloon expandible stent is equipped with small cell structure which are less flexible but have greater radial force.
These are reserved for use in known highly calcified stenosis in straight vessels.
Bifurcated vessels present unique technical problems, largely because of their Y-shape.
Kissing stents are known and used to open bifurcated vessels. They typically consist of two separate stents which when located beyond the bifurcated vessel junction are clipped together and then individually expanded. The upper region of both stents contact each other but are not contiguous. This requires considerable interventional endovascular skill to insert the kissing stent. Kissing stents have been reported to fail due to unclipping of the two stents in situ. Bifurcated stents, on the other hand, are pre-formed Y-shaped stents that are reserved for patients with aorto-iliac aneurysm.
These are high cost and require large vascular access. This type of surgery presents many additional problems to the patient including infection and long recovery time.
Another technique can be used specially in coronaries. Crush stenting consists of two crossing stents, which are delivered through the bifurcation after crushing and remodeling the two stent using balloon. Disadvantageously, this too requires high technicality and is time consuming.
Thus, there is a clear unmet medical need for an improved stent for use in occluded bifurcated vessels.
BRIEF SUMMARY
I have significantly reduced, or essentially eliminated, the problems associated with the designs described above by designing an endovascular and biliary prosthetic stent that reproduces the anatomy of bifurcation. Advantageously, the stent is useful for single access endovascular delivery and is applicable for all types of bifurcations such as arterial, venous and biliary bifurcation. The stent is designed to reproduce the anatomy of a bifurcated vessel and when inserted provides significantly reduced flow resistance. The novel and unobvious stent uses a central open cell concept which permits location of two mesh walled conduits in the two vessels of the bifurcated vessel This design might be useful in coronary and bronchic bifurcation.
Accordingly, in one embodiment there is provided a stent for use with occluded bifurcated vessels, the stent comprising:
a first elongate conduit having a first mesh sidewall and a first angled end;
a second elongate conduit having a second mesh sidewall and a second angled end;
and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap, the connector member being hingeably deformable so that the first and second conduits are angled towards each other for location near a junction between the bifurcated vessels so as to locate the first and second elongate conduits in each of the bifurcated vessels.
In one example, the connector member is an open cell located at a junction between the first and second angled ends.
In another example, the first elongate conduit has a first longitudinal axis;
and the second elongate conduit has a second longitudinal axis. In a default configuration, the first and second longitudinal axes are disposed co-linear. The default configuration permits entry of the first and second conduits into a main vessel located away from the
TECHNICAL FIELD
The present generally concerns stents, and more specifically for a stent for use in narrowed vascular bifurcation.
BACKGROUND
Anatomic vessels have lumens in which a stenosis can form causing partial or complete occlusion. Stents are well-known and widely used in interventional radiology and cardiology to maintain the vessel open. Two designs are currently available, namely self expandible and balloon expandible stents. Both stent designs have metallic mesh-shaped structures, which when deployed in the vessel through minimally invasive vascular access, form scaffolding to avoid the recoil of the vessel wall so as to keep the vessel open. The mesh includes different, large cells which give the self-expanding stent more flexibility with less radial force, whereas the balloon expandible stent is equipped with small cell structure which are less flexible but have greater radial force.
These are reserved for use in known highly calcified stenosis in straight vessels.
Bifurcated vessels present unique technical problems, largely because of their Y-shape.
Kissing stents are known and used to open bifurcated vessels. They typically consist of two separate stents which when located beyond the bifurcated vessel junction are clipped together and then individually expanded. The upper region of both stents contact each other but are not contiguous. This requires considerable interventional endovascular skill to insert the kissing stent. Kissing stents have been reported to fail due to unclipping of the two stents in situ. Bifurcated stents, on the other hand, are pre-formed Y-shaped stents that are reserved for patients with aorto-iliac aneurysm.
These are high cost and require large vascular access. This type of surgery presents many additional problems to the patient including infection and long recovery time.
Another technique can be used specially in coronaries. Crush stenting consists of two crossing stents, which are delivered through the bifurcation after crushing and remodeling the two stent using balloon. Disadvantageously, this too requires high technicality and is time consuming.
Thus, there is a clear unmet medical need for an improved stent for use in occluded bifurcated vessels.
BRIEF SUMMARY
I have significantly reduced, or essentially eliminated, the problems associated with the designs described above by designing an endovascular and biliary prosthetic stent that reproduces the anatomy of bifurcation. Advantageously, the stent is useful for single access endovascular delivery and is applicable for all types of bifurcations such as arterial, venous and biliary bifurcation. The stent is designed to reproduce the anatomy of a bifurcated vessel and when inserted provides significantly reduced flow resistance. The novel and unobvious stent uses a central open cell concept which permits location of two mesh walled conduits in the two vessels of the bifurcated vessel This design might be useful in coronary and bronchic bifurcation.
Accordingly, in one embodiment there is provided a stent for use with occluded bifurcated vessels, the stent comprising:
a first elongate conduit having a first mesh sidewall and a first angled end;
a second elongate conduit having a second mesh sidewall and a second angled end;
and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap, the connector member being hingeably deformable so that the first and second conduits are angled towards each other for location near a junction between the bifurcated vessels so as to locate the first and second elongate conduits in each of the bifurcated vessels.
In one example, the connector member is an open cell located at a junction between the first and second angled ends.
In another example, the first elongate conduit has a first longitudinal axis;
and the second elongate conduit has a second longitudinal axis. In a default configuration, the first and second longitudinal axes are disposed co-linear. The default configuration permits entry of the first and second conduits into a main vessel located away from the
2 junction between the bifurcated vessels. In an operable configuration, the first and second conduits are hingeably deformed so as to locate the first and second elongate conduits in each of the bifurcated vessels, the first and second longitudinal axes being disposed co-linear with the bifurcated vessel.
In one example, one of the vessels has a stenosis.
In one example, both of the vessels have a stenosis.
In one example, the bifurcated vessel is arterial.
In one example, the bifurcated vessel is venous.
Accordingly, in another embodiment, there is provided a method of inserting a stent into a bifurcated vessel having at least one stenosis, the method comprising:
locating one end of the stent into a main vessel away from a junction of a bifurcated vessel, the stent having a first elongate conduit having a first mesh sidewall and a first angled end, a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap;
hingeably deforming the stent about the V-shaped gap so that the first and second conduits are angled towards each other; and locating the first and second conduits in each of the bifurcated vessels so that the connector member is located near a junction between the bifurcated vessels.
Accordingly, in another embodiment, there is provided a method of treating a subject having at least one stenosis in a bifurcated vessel, the method comprising:
locating one end of the stent into a main vessel away from a junction of a bifurcated vessel, the stent having a first elongate conduit having a first mesh sidewall and a first angled end, a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap;
In one example, one of the vessels has a stenosis.
In one example, both of the vessels have a stenosis.
In one example, the bifurcated vessel is arterial.
In one example, the bifurcated vessel is venous.
Accordingly, in another embodiment, there is provided a method of inserting a stent into a bifurcated vessel having at least one stenosis, the method comprising:
locating one end of the stent into a main vessel away from a junction of a bifurcated vessel, the stent having a first elongate conduit having a first mesh sidewall and a first angled end, a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap;
hingeably deforming the stent about the V-shaped gap so that the first and second conduits are angled towards each other; and locating the first and second conduits in each of the bifurcated vessels so that the connector member is located near a junction between the bifurcated vessels.
Accordingly, in another embodiment, there is provided a method of treating a subject having at least one stenosis in a bifurcated vessel, the method comprising:
locating one end of the stent into a main vessel away from a junction of a bifurcated vessel, the stent having a first elongate conduit having a first mesh sidewall and a first angled end, a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap;
3
4 hingeably deforming the stent about the V-shaped gap so that the first and second conduits are angled towards each other; and locating the first and second conduits in each of the bifurcated vessels so that the connector member is located near a junction between the bifurcated vessels.
In one example, the subject is a mammal.
In one example, the subject is a human In one example, one of the vessels has a stenosis.
In one example, both of the vessels have a stenosis.
In one example, the bifurcated vessel is arterial.
In one example, the bifurcated vessel is venous.
In one example, the bifurcated vessel is biliary.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other features of that described herein will become more apparent from the following description in which reference is made to the appended drawings wherein:
Fig. 1 is a diagrammatic representation of a bifurcated vessel showing stenosis;
Fig. 2 is a diagrammatic representation of a V-shaped stent located in a partially occluded bifurcated vessel Fig. 3 is a diagrammatic representation of a diagram of a stent in a default configuration for insertion into a main vessel; and Fig. 4 is a diagrammatic representation of the stent delivered to a bifurcated vessel.
DETAILED DESCRIPTION
Definitions Unless otherwise specified, the following definitions apply:
The singular forms "a", "an" and "the" include corresponding plural references unless the context clearly dictates otherwise.
As used herein, the term "comprising" is intended to mean that the list of elements following the word "comprising" are required or mandatory but that other elements are optional and may or may not be present.
As used herein, the term "consisting of" is intended to mean including and limited to whatever follows the phrase "consisting of". Thus, the phrase "consisting of"
indicates that the listed elements are required or mandatory and that no other elements may be present.
As used herein, the term "subject" is intended to mean humans and non-human mammals such as primates, cats, dogs, swine, cattle, sheep, goats, horses, rabbits, rats, mice and the like.
As used herein, the term "treating" or "treatment" is intended to mean treatment of a disease-state associated with at least one stenosis a bifurcated vessel.
Referring to FIGs. 1 and 2, there is shown generally at 10 a prosthetic stent for surgical use in mammalian subjects having occluded bifurcated vessels 12. In the examples shown, the mammalian subject is a human subject. In the example shown, the bifurcated vessel 12 is an iliac bifurcation located in communication with an aorta 14.
The bifurcated vessel 12 includes two vessel 16, 18, which in this example have a stenosis 19. The bifurcated vessels 12 that are amenable to the stent 10 include, but are not limited to, arterial vessels, venous vessels and biliary vessel. The stent 10 may be used to treat the human subject in which one of the vessels has a stenosis or both of the vessels have a stenosis.
Referring now to Figs. 3 and 4, the stent 10 includes a first elongate conduit 22 which has a first mesh sidewall 24 and a first angled end 26. and a second elongate conduit 28 having a second mesh sidewall 30 and a second angled end 32. In the example shown, the stent is made from Nitinol alloy with the first and second angled ends 26, 32 being cut to a range of between about 30 to 45 degrees. An open cell connector member 34 connects the first and second angled ends 26, 32 together so that they face each other to form a V-shaped gap 36.
In one example, the subject is a mammal.
In one example, the subject is a human In one example, one of the vessels has a stenosis.
In one example, both of the vessels have a stenosis.
In one example, the bifurcated vessel is arterial.
In one example, the bifurcated vessel is venous.
In one example, the bifurcated vessel is biliary.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other features of that described herein will become more apparent from the following description in which reference is made to the appended drawings wherein:
Fig. 1 is a diagrammatic representation of a bifurcated vessel showing stenosis;
Fig. 2 is a diagrammatic representation of a V-shaped stent located in a partially occluded bifurcated vessel Fig. 3 is a diagrammatic representation of a diagram of a stent in a default configuration for insertion into a main vessel; and Fig. 4 is a diagrammatic representation of the stent delivered to a bifurcated vessel.
DETAILED DESCRIPTION
Definitions Unless otherwise specified, the following definitions apply:
The singular forms "a", "an" and "the" include corresponding plural references unless the context clearly dictates otherwise.
As used herein, the term "comprising" is intended to mean that the list of elements following the word "comprising" are required or mandatory but that other elements are optional and may or may not be present.
As used herein, the term "consisting of" is intended to mean including and limited to whatever follows the phrase "consisting of". Thus, the phrase "consisting of"
indicates that the listed elements are required or mandatory and that no other elements may be present.
As used herein, the term "subject" is intended to mean humans and non-human mammals such as primates, cats, dogs, swine, cattle, sheep, goats, horses, rabbits, rats, mice and the like.
As used herein, the term "treating" or "treatment" is intended to mean treatment of a disease-state associated with at least one stenosis a bifurcated vessel.
Referring to FIGs. 1 and 2, there is shown generally at 10 a prosthetic stent for surgical use in mammalian subjects having occluded bifurcated vessels 12. In the examples shown, the mammalian subject is a human subject. In the example shown, the bifurcated vessel 12 is an iliac bifurcation located in communication with an aorta 14.
The bifurcated vessel 12 includes two vessel 16, 18, which in this example have a stenosis 19. The bifurcated vessels 12 that are amenable to the stent 10 include, but are not limited to, arterial vessels, venous vessels and biliary vessel. The stent 10 may be used to treat the human subject in which one of the vessels has a stenosis or both of the vessels have a stenosis.
Referring now to Figs. 3 and 4, the stent 10 includes a first elongate conduit 22 which has a first mesh sidewall 24 and a first angled end 26. and a second elongate conduit 28 having a second mesh sidewall 30 and a second angled end 32. In the example shown, the stent is made from Nitinol alloy with the first and second angled ends 26, 32 being cut to a range of between about 30 to 45 degrees. An open cell connector member 34 connects the first and second angled ends 26, 32 together so that they face each other to form a V-shaped gap 36.
5 As best seen in Figs. 2 and 4, the connector member 34 is hingeably deformable about a hinged junction 38 so that the first and second conduits 22, 28 are angled towards each other, By hingeably deforming (or bending) the conduits 22, 28 about the hinged junction 38, the V-shaped gap 36 widens and permits the stent 10 to be located near a junction 40 between the bifurcated vessels 16, 18 so as to locate the first and second elongate conduits 22, 28 in each of the bifurcated vessels 16, 18.
As best seen in Figs. 3 and 4, the first elongate conduit 22 has a first longitudinal axis 42 and the second elongate conduit 28 has a second longitudinal axis 44. In a default configuration, as shown in Fig. 3, the first and second longitudinal axes 42, 44 are disposed co-linear. The stent m when in the default configuration permits entry of the first and second conduits 22, 28 into a main vessel located away from the junction 40 between the bifurcated vessels 16, 18. In an operable configuration, the first and second conduits 22, 28 are hingeably deformed so as to locate the first and second elongale conduils 22, 28 in each of the bifurcaled vessels 16, 18 so lhal he first. and second longitudinal axes 42, 44 are disposed co-linear with the bifurcated vessel to permit expansion and retention in the vessels. Advantageously, the stent 10 is a one-piece, modular system which permits accurate surgical placement with minimal invasion and time spent in the operating theater.
Referring specifically to Fig 3, a closed cell is located opposed to the open cell. In the closed cell structure, the mesh structure is formed by several cells. The closed cell feature of the first and second mesh sidewalls has cell geometry which connects consistently throughout to form complete and bridging "diamond-shaped" cells that are welded together at each cell junction. The central open cell, on the other hand, is attached to adjacent cells at only one or two edge to make the stent more flexible.
Other Embodiments From the foregoing description, it will be apparent to one of ordinary skill in the art that variations and modifications may be made to the embodiments described herein to adapt it to various usages and conditions.
As best seen in Figs. 3 and 4, the first elongate conduit 22 has a first longitudinal axis 42 and the second elongate conduit 28 has a second longitudinal axis 44. In a default configuration, as shown in Fig. 3, the first and second longitudinal axes 42, 44 are disposed co-linear. The stent m when in the default configuration permits entry of the first and second conduits 22, 28 into a main vessel located away from the junction 40 between the bifurcated vessels 16, 18. In an operable configuration, the first and second conduits 22, 28 are hingeably deformed so as to locate the first and second elongale conduils 22, 28 in each of the bifurcaled vessels 16, 18 so lhal he first. and second longitudinal axes 42, 44 are disposed co-linear with the bifurcated vessel to permit expansion and retention in the vessels. Advantageously, the stent 10 is a one-piece, modular system which permits accurate surgical placement with minimal invasion and time spent in the operating theater.
Referring specifically to Fig 3, a closed cell is located opposed to the open cell. In the closed cell structure, the mesh structure is formed by several cells. The closed cell feature of the first and second mesh sidewalls has cell geometry which connects consistently throughout to form complete and bridging "diamond-shaped" cells that are welded together at each cell junction. The central open cell, on the other hand, is attached to adjacent cells at only one or two edge to make the stent more flexible.
Other Embodiments From the foregoing description, it will be apparent to one of ordinary skill in the art that variations and modifications may be made to the embodiments described herein to adapt it to various usages and conditions.
6
Claims (20)
1. A stent for use with occluded bifurcated vessels, the stent comprising:
a first elongate conduit having a first mesh sidewall and a first angled end;
a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap, the connector member being hingeably deformable so that the first and second conduits are angled towards each other for location near a junction between the bifurcated vessels so as to locate the first and second elongate conduits in each of the bifurcated vessels.
a first elongate conduit having a first mesh sidewall and a first angled end;
a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap, the connector member being hingeably deformable so that the first and second conduits are angled towards each other for location near a junction between the bifurcated vessels so as to locate the first and second elongate conduits in each of the bifurcated vessels.
2. The stent, according to claim 1, in which the connector member is an open cell located at a junction between the first and second angled ends.
3. The stent, according to claim 1, in which the first elongate conduit has a first longitudinal axis; and the second elongate conduit has a second longitudinal axis.
4. The stent, according to claim 3, in which in a default configuration, the first and second longitudinal axes are disposed co-linear.
5. The stent, according to claim 4, in which the default configuration permits entry of the first and second conduits into a main vessel located away from the junction between the bifurcated vessels.
6. The stent, according to claim 3, in which in an operable configuration, the first and second conduits are hingeably deformed so as to locate the first and second elongate conduits in each of the bifurcated vessels, the first and second longitudinal axes being disposed co-linear with the bifurcated vessel.
7. The stent, according to claim 1, in which one of the vessels has a stenosis.
8. The stent, according to claim 1, in which both of the vessels have a stenosis.
9. The stent, according to claim 1, in which the bifurcated vessel is arterial
10. The stent, according to claim 1, in which the bifurcated vessel is venous.
11. The stent, according to claim 1, in which the bifurcated vessel is biliary.
12. A method of inserting a stent into a bifurcated vessel having at least one stenosis, the method comprising:
locating one end of the stent into a main vessel away from a junction of a bifurcated vessel, the stent having a first elongate conduit having a first mesh sidewall and a first angled end, a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap;
hingeably deforming the stent about the V-shaped gap so that the first and second conduits are angled towards each other; and locating the first and second conduits in each of the bifurcated vessels so that the connector member is located near a junction between the bifurcated vessels.
locating one end of the stent into a main vessel away from a junction of a bifurcated vessel, the stent having a first elongate conduit having a first mesh sidewall and a first angled end, a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap;
hingeably deforming the stent about the V-shaped gap so that the first and second conduits are angled towards each other; and locating the first and second conduits in each of the bifurcated vessels so that the connector member is located near a junction between the bifurcated vessels.
13. A method of treating a subject having at least one stenosis in a bifurcated vessel, the method comprising:
locating one end of the stent into a main vessel away from a junction of a bifurcated vessel, the stent having a first elongate conduit having a first mesh sidewall and a first angled end, a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap;
hingeably deforming the stent about the V-shaped gap so that the first and second conduits are angled towards each other; and locating the first and second conduits in each of the bifurcated vessels so that the connector member is located near a junction between the bifurcated vessels.
locating one end of the stent into a main vessel away from a junction of a bifurcated vessel, the stent having a first elongate conduit having a first mesh sidewall and a first angled end, a second elongate conduit having a second mesh sidewall and a second angled end; and a connector member for connecting the first and second angled ends so that they face each other to form a V-shaped gap;
hingeably deforming the stent about the V-shaped gap so that the first and second conduits are angled towards each other; and locating the first and second conduits in each of the bifurcated vessels so that the connector member is located near a junction between the bifurcated vessels.
14. The method, according to claim 13, in which the subject is a mammal.
15. The method, according to claim 13, in which the subject is a human
16. The method, according to claim 13, in which one of the vessels has a stenosis.
17. The method, according to claim 13, in which both of the vessels have a stenosis.
18. The method, according to claim 13, in which the bifurcated vessel is arterial
19. The method, according to claim 13, in which the bifurcated vessel is venous.
20. The method, according to claim 13, in which the bifurcated vessel is biliary.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163208015P | 2021-06-08 | 2021-06-08 | |
US63/208,015 | 2021-06-08 | ||
PCT/CA2022/050912 WO2022256924A1 (en) | 2021-06-08 | 2022-06-08 | Stent for bifurcated vessel |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3219718A1 true CA3219718A1 (en) | 2022-12-15 |
Family
ID=84424515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3219718A Pending CA3219718A1 (en) | 2021-06-08 | 2022-06-08 | Stent for bifurcated vessel |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA3219718A1 (en) |
WO (1) | WO2022256924A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008518710A (en) * | 2004-11-03 | 2008-06-05 | セガン,ジャック | Vascular graft and deployment system |
US20100063578A1 (en) * | 2008-09-05 | 2010-03-11 | Aga Medical Corporation | Bifurcated medical device for treating a target site and associated method |
CN201312846Y (en) * | 2008-12-22 | 2009-09-23 | 李家一 | Integrated V-type bracket of bifurcation blood vessel |
CN105744913A (en) * | 2013-09-19 | 2016-07-06 | 曼霍勒公司 | Systems and methods for deploying a luminal prostheses over a carina |
DE102016104302A1 (en) * | 2016-03-09 | 2017-09-14 | Optimed Medizinische Lnstrumente Gmbh | STENT FOR USE AT BIFURCATIONS |
-
2022
- 2022-06-08 WO PCT/CA2022/050912 patent/WO2022256924A1/en active Application Filing
- 2022-06-08 CA CA3219718A patent/CA3219718A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022256924A1 (en) | 2022-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6738392B2 (en) | Intravascular aortic repair device and method of using the same | |
EP1435878B1 (en) | System for fixation of endoluminal devices | |
EP2387374B1 (en) | Paraplegia prevention stent graft | |
US6096071A (en) | Ostial stent | |
EP1585461B1 (en) | Bifurcated stent | |
EP1441782B1 (en) | Interlocking endoluminal stent-graft | |
EP2777610B1 (en) | Endoluminal prosthesis system | |
Haulon et al. | An analysis of the French multicentre experience of fenestrated aortic endografts: medium-term outcomes | |
EP1182990B1 (en) | Improved-guidewire-access modular intraluminal prosthesis with connecting section | |
US20080114441A1 (en) | Endoluminal Prosthesis | |
EP1808149A1 (en) | Intraluminal stent graft | |
US20140350658A1 (en) | Branched stent-graft system | |
US20100049291A1 (en) | Stent with improved resistance to migration | |
US20130041456A1 (en) | Branch vessel prostheses | |
US7824438B2 (en) | Method for placement of a stent assembly in a bifurcated vessel | |
US20070208418A1 (en) | Bifurcated stent | |
JP2000000311A (en) | Stent dilatable in radial direction | |
CA3219718A1 (en) | Stent for bifurcated vessel | |
US11540912B1 (en) | Branch stent for implantation from a main blood vessel and deployment methods | |
CN212630955U (en) | Modular type abdominal aorta bifurcation type tectorial membrane stent | |
Karkos et al. | Endovascular abdominal aortic aneurysm repair in the presence of a kidney transplant: therapeutic considerations | |
Villareal et al. | Early results using bare metal stents with or without coil embolization for AAA exclusion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20231212 |
|
EEER | Examination request |
Effective date: 20231212 |